Presentation TCT 2013 Does Revascularization Benefit Patients with Systolic Dysfunction (With or Without Ischemia and/or Viability) Presenter: Robert Bonow October 29, 2013
Presentation TCT 2013 The Imaging Revolution Will Forever Change the Approach to Coronary Artery Disease Presenter: Stephan Achenbach October 29, 2013
Presentation TCT 2013 TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:... Presenter: Byoung Kwon Lee October 29, 2013
Presentation TCT 2013 Patients Receiving Novel Agents in Whom Life Threatening Bleeding: Practical Recommendations Presenter: Christopher Granger October 29, 2013
Presentation TCT 2013 The Disutility of Nuisance Bleeding: Insights from the TRANSLATE ACS Registry Presenter: Amit P. Amin October 29, 2013
Presentation TCT 2013 TCT-7. Impact Of Early Versus Late Clopidogrel Discontinuation On Stent Thrombosis Following Percutaneous Coronary Intervention With First- And Second-Generation Drug-Eluting... Presenter: Joshua Loh October 29, 2013
Presentation TCT 2013 CoreValve US Pivotal Study Design and Extreme Risk Results Presenter: Steven Yakubov October 29, 2013
Presentation TCT 2013 The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial Presenter: Mahesh V. Madhavan October 29, 2013